Page last updated: 2024-08-24

ibopamine and Heart Disease, Ischemic

ibopamine has been researched along with Heart Disease, Ischemic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Petrie, CJ; van Veldhuisen, DJ; Voors, AA	1

Trials

1 trial(s) available for ibopamine and Heart Disease, Ischemic

Article	Year
Low pulse pressure is an independent predictor of mortality and morbidity in non ischaemic, but not in ischaemic advanced heart failure patients. International journal of cardiology, 2009, Jan-24, Volume: 131, Issue:3 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Blood Pressure; Deoxyepinephrine; Disease Progression; Dopamine Agonists; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Ischemia; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Young Adult	2009

Article

Year

Low pulse pressure is an independent predictor of mortality and morbidity in non ischaemic, but not in ischaemic advanced heart failure patients.

International journal of cardiology, 2009, Jan-24, Volume: 131, Issue:3

Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Blood Pressure; Deoxyepinephrine; Disease Progression; Dopamine Agonists; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Ischemia; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Young Adult

2009